Delivery Order SPE2DB20D1100-SPE2DB25FE3J7
Award Date 8/28/25
Potential Completion Date 8/29/25
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitive delivery order award from the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors. This firm fixed-price delivery order, valued at $8,700.31, is scheduled for completion by July 22, 2025, and represents a component of the company's broader pharmaceutical supply relationship with the federal government. The award carries no set-aside designation and...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on November 10, 2025, for Dupixent 300 mg/2 mL pen injections valued at $9,795.34 with a firm fixed price arrangement. The contract has an ultimate completion date of November 12, 2025, and involves no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $85,299.56 delivery order from the Defense Logistics Agency (DLA) on December 1, 2025, for Dupixent 300 mg/2 ml pen injections. This firm fixed-price delivery order, with an ultimate completion date of December 2, 2025, was awarded competitively without a set-aside designation. The contract represents a continuation of AmerisourceBergen's established role as a critical pharmaceutical supplier to federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,196.29 by the Defense Logistics Agency on November 24, 2025, with an ultimate completion date of November 25, 2025. The award covers the supply of Dupixent 300 mg/2 mL pen injectors. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $12,859.83 from the Defense Logistics Agency (DLA) for Dupixent 300 mg/2 ml pen injectors. This firm fixed price, competitively awarded delivery order was issued on December 15, 2025, with an ultimate completion date of December 16, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 7, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors. This competitively awarded, firm fixed-price delivery order has a ceiling value of $27,543.60 and an ultimate completion date of August 8, 2025. The contract was executed with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $44,617.14 by the Defense Logistics Agency on September 11, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors. The contract is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,770.06 by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Dupixent (dupilumab) 300 mg/2 mL pen injectors. This is a firm fixed-price, non-set-aside competitive award with an ultimate completion date of September 12, 2025. The pharmaceutical will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and distribution hub for federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a $41,074.11 delivery order by the Defense Logistics Agency (DLA) for Dupixent 300 mg/2 mL pen medications with a completion date of November 7, 2025. This competitive award was issued on November 6, 2025, under a firm fixed-price delivery order contract with no set-aside designation. The contract represents a continuation of AmerisourceBergen's substantial role in...
- The Defense Logistics Agency awarded a delivery order valued at $14,595.53 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on October 30, 2025, with an ultimate completion date of October 31, 2025. This non-competitive, firm fixed-price delivery order will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal...